WHO backs wider use of weight-loss medicines, calling obesity a chronic disease
The guidance focuses on GLP-1 therapies – medicines such as liraglutide, semaglutide and tirzepatide – and offers conditional recommendations on...
The guidance focuses on GLP-1 therapies – medicines such as liraglutide, semaglutide and tirzepatide – and offers conditional recommendations on...
A global consortium of world-leading psychiatrists, psychologists, academics and young people have come together to deliver a definitive analysis of...